F552 in Colorado. Pick another state for the same tag.
Against expectation — 2025
Colorado cites F552 more often than its own record predicts
Versus expected share1.87×
1.87 times the share F552 takes of citations nationally.
Share of Colorado citations1.01%
Of every deficiency written in Colorado in 2025, this is the portion that was F552.
Colorado1.01%
National0.54%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Colorado surveyors wrote
F552 findings written in Colorado, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedAugust 13, 2026
Based on interviews and record review, the facility failed to ensure residents and/or their representatives had the right to be informed and make treatment decisions for one (#6) of three residents reviewed for diabetic management out of 13 sample residents. Specifically, the facility failed to ensure Resident #6's representative was informed of and educated on the potential side-effects for the use of a glucagon-like peptide-1 (GLP-1) medication for diabetic management.Findings include:I. Facility policy and procedureThe Notification of Changes policy, undated, was provided by the nursing home administrator (NHA) on 8/13/26 at 2:37 p.m. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction